Chinese Biopharma Firm Zai Lab Completes $150M US Listing, Shares Jump 55%
September 21, 2017 — 12:20 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese biopharmaceutical company Zai Lab Ltd., backed by Chinese venture capital firms including Advantech, OrbiMed Asia Partners and Qiming Venture Partners, has completed an initial... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals